SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $63,000 | +250.0% | 5,618 | +246.4% | 0.00% | – |
| Q2 2017 | $18,000 | +12.5% | 1,622 | +1.4% | 0.00% | – |
| Q1 2017 | $16,000 | -61.0% | 1,600 | -58.2% | 0.00% | – |
| Q4 2016 | $41,000 | +156.2% | 3,832 | +136.1% | 0.00% | – |
| Q3 2016 | $16,000 | -27.3% | 1,623 | -4.5% | 0.00% | – |
| Q2 2016 | $22,000 | -8.3% | 1,700 | -22.7% | 0.00% | – |
| Q1 2016 | $24,000 | -91.9% | 2,200 | -93.2% | 0.00% | – |
| Q4 2015 | $297,000 | +1385.0% | 32,285 | +981.9% | 0.00% | – |
| Q3 2015 | $20,000 | -95.9% | 2,984 | -94.0% | 0.00% | – |
| Q2 2015 | $487,000 | +14.1% | 49,679 | +3.2% | 0.00% | – |
| Q1 2015 | $427,000 | +2568.8% | 48,147 | +2574.8% | 0.00% | – |
| Q4 2014 | $16,000 | +14.3% | 1,800 | -10.0% | 0.00% | – |
| Q3 2014 | $14,000 | -22.2% | 2,000 | -42.9% | 0.00% | – |
| Q2 2014 | $18,000 | +63.6% | 3,500 | +40.0% | 0.00% | – |
| Q1 2014 | $11,000 | +120.0% | 2,500 | +150.0% | 0.00% | – |
| Q4 2013 | $5,000 | -95.2% | 1,000 | -95.2% | 0.00% | – |
| Q3 2013 | $105,000 | +1650.0% | 20,688 | +1508.7% | 0.00% | – |
| Q2 2013 | $6,000 | – | 1,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
| Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
| Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
| GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
| MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
| Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
| Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
| TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
| BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |